As of 2025-05-21, the Fair Value of Korea Arlico Pharm Co Ltd (260660.KQ) is -1,747.57 KRW. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7,460.00 KRW, the upside of Korea Arlico Pharm Co Ltd is -123.43%.
With the market price of 7,460.00 KRW and our fair value calculation, Korea Arlico Pharm Co Ltd (260660.KQ) is not a good investment. Investing in 260660.KQ stocks now will result in a potential loss of 123.43%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 8,372.00 | 4,929.66 | 8,034.26 | 3,060.92 | -5,358.05 | 3,807.76 |
| YoY growth | -16.54% | -41.12% | 62.98% | -61.90% | -275.05% | -66.33% |
| Market Cap (mil) | 114,361.80 |
| P/E | |
| Forward P/E |
| EPS | -349.51 |
| Avg earnings growth rate | -66.33% |
| TTM earnings | -5,358.05 |